| 000 | 00973 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517112123.0 | ||
| 264 | 0 | _c20171010 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.14728 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrmerod, A D | |
| 245 | 0 | 0 |
_aBrodalumab established as an effective interleukin-17 receptor antagonist in psoriasis. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c08 2016 |
||
| 300 |
_a243-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterleukin-17 |
| 650 | 0 | 4 | _aPsoriasis |
| 650 | 0 | 4 |
_aReceptors, Interleukin-17 _xantagonists & inhibitors |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 175 _gno. 2 _gp. 243-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.14728 _zAvailable from publisher's website |
| 999 |
_c26338013 _d26338013 |
||